Back to
CITADEL ADVISORS LLC
BCTX2 quarters
Position history for
CITADEL ADVISORS LLC's holdings in BRIACELL THERAPEUTICS CORP
CITADEL ADVISORS LLC previously held 0 shares of BCTX (BRIACELL THERAPEUTICS CORP), worth $0 as of 2025-Q4.
Final Value
$0
Final Shares
0
Total Value Change
-$121,605
Total Shares Change
-11,055
Quarter-by-Quarter History
Other major holders of BCTX: UBS Group AG, JANE STREET GROUP, LLC, MORGAN STANLEY